The median age of patients who experienced the inflammation after a second vaccine dose was 24, according to U. The agency said it is still assessing the risk from the condition and has not yet concluded that there was a causal relationship between the vaccines and cases of myocarditis or pericarditis. While some patients required hospitalization, most have fully recovered from their symptoms, the CDC said. There were 283 observed cases of heart inflammation after the second vaccine dose in those aged 16 to 24 in the VAERS data. Shimabukuro said there was a predominance of males in younger age groups among the reported heart inflammation cases.
The median age of patients who experienced the inflammation after a second vaccine dose was 24, according to the VAERS data. About 130 million people in the United States have received both doses of one of the mRNA vaccines. «It is important to understand that a careful assessment of the reports is ongoing and it has not been concluded that the mRNA COVID-19 vaccines cause myocarditis or pericarditis,» the company said in a statement. Moderna said it also has not established a causal association with the condition and its vaccine.
It said it is actively working with public health and regulatory authorities to further assess the issue. The CDC said it will hold a meeting of its Advisory Committee on Immunization Practices next week to further evaluate the evidence and assess the risk of myocarditis following mRNA vaccination for COVID-19.